MedPath
FDA Approval

INQOVI

May 5, 2022

HUMAN PRESCRIPTION DRUG LABEL

Cedazuridine(100 mg in 1 1)
Decitabine(35 mg in 1 1)

Products (1)

INQOVI

64842-0727

NDA212576

NDA (C73594)

ORAL

March 30, 2022

Code: 39IS23Q1EWClass: ACTIBQuantity: 100 mg in 1 1
Code: 776B62CQ27Class: ACTIBQuantity: 35 mg in 1 1
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WOClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
POLYVINYL ALCOHOL, UNSPECIFIEDInactive
Code: 532B59J990Class: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675Class: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1AClass: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
© Copyright 2025. All Rights Reserved by MedPath